The aim of this study was to evaluate the associations between the rs3918396 G>A and rs528557 C>G polymorphisms in the disinterring and metalloproteinase domain 33 (ADAM33) gene and asthma risk. We searched CISCOM, CINAHL, Web of Science, PubMed, Google Scholar, EBSCO, Cochrane Library, and CBM databases from inception through August 1st, 2013 without language restrictions. Meta-analysis was performed using the STATA 12.0 software. Crude odds ratios (ORs) with their 95% confidence intervals (95% CI) were calculated. Thirteen case-control studies were included with a total of 7104 asthma patients and 8172 healthy controls. Our meta-analysis results revealed that ADAM33 rs528557 C>G polymorphism was associated with an increased risk of asthma (all p<0.05). However, we found no correlation between the ADAM33 rs3918396 G>A polymorphism and asthma risk (all p>0.05). Subgroup analysis by ethnicity indicated that the ADAM33 rs528557 C>G polymorphism might be strongly associated with an increased risk of asthma among both Caucasian and Asian populations (All p<0.05). No significant association was found between the ADAM33 rs3918396 G>A polymorphism and the risk of asthma among the studied ethnicities (All p>0.05). The present meta-analysis suggests that the ADAM33 rs528557 C>G polymorphism may contribute to susceptibility to asthma. Thus, the ADAM33 rs528557 C>G polymorphism may be utilized as a biomarker for early diagnosis of asthma.
Get full access to this article
View all access options for this article.
References
1.
AkinbamiL.J., MoormanJ.E., BaileyC., ZahranH.S., KingM., JohnsonC.A., and LiuX. (2012). Trends in asthma prevalence, health care use, and mortality in the United States, 2001–2010. NCHS Data Brief. 1–8.
2.
ArnoldI.C., DehzadN., ReuterS., MartinH., BecherB., TaubeC., and MullerA. (2011). Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest, 121, 3088–3093.
3.
AwasthiS., TripathiP., GaneshS., and HusainN. (2011). Association of ADAM33 gene polymorphisms with asthma in Indian children. J Hum Genet, 56, 188–195.
4.
BijanzadehM., RamachandraN.B., MaheshP.A., MysoreR.S., KumarP., ManjunathB.S., and JayarajB.S. (2010). Association of IL-4 and ADAM33 gene polymorphisms with asthma in an Indian population. Lung, 188, 415–422.
5.
BlakeyJ.D., SayersI., RingS.M., StrachanD.P., and HallI.P. (2009). Positionally cloned asthma susceptibility gene polymorphisms and disease risk in the British 1958 Birth Cohort. Thorax, 64, 381–387.
6.
BlumenthalM.N. (2012). Genetic, epigenetic, and environmental factors in asthma and allergy. Ann Allergy Asthma Immunol, 108, 69–73.
7.
ChiX.Y., XiaoW., WX.Q., LiQ., W, JiangH.J., WangL.C., and WangJ.P. (2012). Study on relationship between genetic polymorphisms of ADAM33 and susceptibility to bronchial asthma. Int J Respir, 06, 12–16.
8.
DaviesD.E. (2009). The role of the epithelium in airway remodeling in asthma. Proc Am Thorac Soc, 6, 678–682.
9.
de FariaI.C., de FariaE.J., ToroA.A., RibeiroJ.D., and BertuzzoC.S. (2008). Association of TGF-beta1, CD14, IL-4, IL-4R and ADAM33 gene polymorphisms with asthma severity in children and adolescents. J Pediatr (Rio J), 84, 203–210.
10.
DupontW.D., and PlummerW.D.Jr. (1990). Power and sample size calculations. A review and computer program. Control Clin Trials, 11, 116–128.
11.
HirotaT., HasegawaK., ObaraK., MatsudaA., AkahoshiM., NakashimaK., ShirakawaT., DoiS., et al. (2006). Association between ADAM33 polymorphisms and adult asthma in the Japanese population. Clin Exp Allergy, 36, 884–891.
12.
HodgkinsonL.M., WangL., DuncanG., EdwardsD.R., and WormstoneI.M. (2010). ADAM and ADAMTS gene expression in native and wound healing human lens epithelial cells. Mol Vis, 16, 2765–2776.
13.
HolgateS.T. (2008). The airway epithelium is central to the pathogenesis of asthma. Allergol Int, 57, 1–10.
14.
HolgateS.T., DaviesD.E., PowellR.M., and HollowayJ.W. (2005). ADAM33: a newly identified gene in the pathogenesis of asthma. Immunol Allergy Clin North Am, 25, 655–668.
15.
HolgateS.T., DaviesD.E., PowellR.M., and HollowayJ.W. (2006a). ADAM33: a newly identified protease involved in airway remodelling. Pulm Pharmacol Ther, 19, 3–11.
16.
HolgateS.T., YangY., HaitchiH.M., PowellR.M., HollowayJ.W., YoshisueH., PangY.Y., CakebreadJ., et al. (2006b). The genetics of asthma: ADAM33 as an example of a susceptibility gene. Proc Am Thorac Soc, 3, 440–443.
17.
HowardT.D., PostmaD.S., JongepierH., MooreW.C., KoppelmanG.H., ZhengS.L., XuJ., BleeckerE.R., et al. (2003). Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations. J Allergy Clin Immunol, 112, 717–722.
18.
JieZ., HuZ., BaiC., and JinM. (2011). ADAM33 gene polymorphisms associate with asthma susceptibility and severity in East China han population. J Asthma, 48, 979–985.
19.
JieZ., JinM., CaiY., BaiC., ShenY., YuanZ., HuY., and HolgateS. (2009). The effects of Th2 cytokines on the expression of ADAM33 in allergen-induced chronic airway inflammation. Respir Physiol Neurobiol, 168, 289–294.
20.
KleinT., and BischoffR. (2011). Active metalloproteases of the A Disintegrin and Metalloprotease (ADAM) family: biological function and structure. J Proteome Res, 10, 17–33.
21.
LambrechtB.N., and HammadH. (2012). The airway epithelium in asthma. Nat Med, 18, 684–692.
22.
LeeJ.H., ParkH.S., ParkS.W., JangA.S., UhS.T., RhimT., ParkC.S., HongS.J., et al. (2004). ADAM33 polymorphism: association with bronchial hyper-responsiveness in Korean asthmatics. Clin Exp Allergy, 34, 860–865.
23.
LiangS., WeiX., GongC., WeiJ., ChenZ., and DengJ. (2013). A disintegrin and metalloprotease 33 (ADAM33) gene polymorphisms and the risk of asthma: a meta-analysis. Hum Immunol, 74, 648–657.
24.
LittleJ., HigginsJ.P., IoannidisJ.P., MoherD., GagnonF., von ElmE., KhouryM.J., CohenB., et al. (2009). Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol, 24, 37–55.
25.
LouisR., SchleichF., CorhayJ.L., and LouisE. (2012). Asthma: a complex disease determined by genetic and environmental factors. Rev Med Liege, 67, 286–291.
26.
MiyakeY., TanakaK., and ArakawaM. (2012a). ADAM33 genetic polymorphisms, smoking, and rhinoconjunctivitis in Japanese women: the Kyushu Okinawa Maternal and Child Health Study. Hum Immunol, 73, 411–415.
27.
MiyakeY., TanakaK., and ArakawaM. (2012b). ADAM33 polymorphisms, smoking and asthma in Japanese women: the Kyushu Okinawa Maternal and Child Health Study. Int J Tuberc Lung Dis, 16, 974–979.
28.
MoffattM.F., GutI.G., DemenaisF., StrachanD.P., BouzigonE., HeathS., von MutiusE., FarrallM., et al. (2010). A large-scale, consortium-based genomewide association study of asthma. N Engl J Med, 363, 1211–1221.
29.
MoormanJ.E., ZahranH., TrumanB.I., and MollaM.T. (2011). Current asthma prevalence—United States, 2006–2008. MMWR Surveill Summ, 60Suppl, 84–86.
30.
MukherjeeA.B., and ZhangZ. (2011). Allergic asthma: influence of genetic and environmental factors. J Biol Chem, 286, 32883–32889.
31.
Nicodemus-JohnsonJ., LaxmanB., SternR.K., SudiJ., TierneyC.N., NorwickL., HogarthD.K., McConvilleJ.F., et al. (2013). Maternal asthma and microRNA regulation of soluble HLA-G in the airway. J Allergy Clin Immunol, 131, 1496–1503.
32.
NoguchiE., OhtsukiY., TokunagaK., Yamaoka-SageshimaM., IchikawaK., AokiT., ShibasakiM., and ArinamiT. (2006). ADAM33 polymorphisms are associated with asthma susceptibility in a Japanese population. Clin Exp Allergy, 36, 602–608.
33.
PetersJ.L., SuttonA.J., JonesD.R., AbramsK.R., and RushtonL. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA, 295, 676–680.
34.
Pino-YanesM., CorralesA., CumplidoJ., PozaP., Sánchez-MachínI., Sánchez-PalaciosA., FigueroaJ., Acosta-FernándezO., et al. (2013) Assessing the validity of asthma associations for eight candidate genes and age at diagnosis effects. PLoS One, 8, e73157.
35.
PostmaD.S., and HowardT. (2004). ADAM33 gene: confirming a gene without linkage. Clin Exp Allergy, 34, 1–3.
36.
PowellR.M., HamiltonL.M., HolgateS.T., DaviesD.E., and HollowayJ.W. (2003). ADAM33: a novel therapeutic target for asthma. Expert Opin Ther Targets, 7, 485–494.
37.
QuS., SunD., WangY., ZhangC., LvY., and YaoL. (2011). Association of ADAM33 polymorphisms with childhood asthma in a northern Chinese population. Exp Mol Pathol, 91, 775–779.
38.
ReissK., and SaftigP. (2009). The “a disintegrin and metalloprotease” (ADAM) family of sheddases: physiological and cellular functions. Semin Cell Dev Biol, 20, 126–137.
39.
SuD., ZhangX., SuiH., LuF., JinL., and ZhangJ. (2008). Association of ADAM33 gene polymorphisms with adult allergic asthma and rhinitis in a Chinese Han population. BMC Med Genet, 9, 82.
40.
SvenM., LiangL., DepnerM., KloppN., RuetherA., KumarA., SchedelM., VogelbergC., et al. (2010). Unifying candidate gene and GWAS approaches in asthma. PLoS One, 5, e13894.
41.
ThongngarmT., JameekornrakA., LimwongseC., SangasapaviliyaA., JirapongsananurukO., AssawamakinA., ChaiyaratanaN., LuangwedchakarnV., et al. (2008). Association between ADAM33 polymorphisms and asthma in a Thai population. Asian Pac J Allergy Immunol, 26, 205–211.
42.
TripathiP., AwasthiS., PrasadR., HusainN., and GaneshS. (2011). Association of ADAM33 gene polymorphisms with adult-onset asthma and its severity in an Indian adult population. J Genet, 90, 265–273.
43.
Van EerdeweghP., LittleR.D., DupuisJ., Del MastroR.G., FallsK., SimonJ., TorreyD., PanditS., et al. (2002). Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature, 418, 426–430.
44.
VerlaanD.J., BerlivetS., HunninghakeG.M., MadoreA.M., LariviereM., MoussetteS., GrundbergE., KwanT., et al. (2009). Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease. Am J Hum Genet, 85, 377–393.
45.
YeH., LuoY.L., and LaiW.Y. (2009). ADAM33 polymorphisms with asthma susceptibility and severity in adolescent asthma. J Clin Intern Med, 26, 383–385.
46.
YuH.C., LiY.Q., Wangl.J., JiangC.S., ZhuW.H., MengL.S., and LvS.M. (2011). Polymorphism of a disintergrin and metalloprotease 33 gene S2 of Han children with asthama in Shanxi Guangzhou. J Apple Clin Pediatr, 26, 650–652.
47.
ZhouJ., SunD., XuL., SunL., FuS., and LiY. (2011). ADAM33 as a psoriasis susceptibility gene in the Han population of northeastern China. Dermatology, 223, 356–362.
48.
ZintzarasE., and IoannidisJ.P. (2005). HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics, 21, 3672–3673.
